Project #4214
Adaptation of the Minimum Anticipated Biological Effect Level (MABEL) Approach to Emerging Compounds of Interest
$145,329
Principal Investigator
Richard
Pleus
Research Manager
Dr. Djanette Khiari
Contractor
Intertox Inc.
Abstract
Developed and applied an innovative scientifically-based method to develop health-protective Acceptable Daily Intakes (ADIs) for new compounds of emerging interest to the water industry that have the potential for significant toxicity to sensitive population groups, including pharmaceutical and personal care product (PPCP) ingredients, hormonally active compounds, and nanomaterials. Published in 2011.
Related Projects
Project #4992
Project #1631
Project #4790
Project #5125
Project #5171
Project #5103